240 related articles for article (PubMed ID: 1610407)
21. Tetrahydroaminoacridine affects the cholinergic function of blood-brain barrier.
Catalán RE; Martínez AM; Aragonés MD; Miguel BG; Hernández F; Cruz E
Life Sci; 1993; 53(14):1165-72. PubMed ID: 8371630
[TBL] [Abstract][Full Text] [Related]
22. Acetylcholinesterase inhibition and protection by dizocilpine (MK-801) enantiomers.
Galli A; Mori F
J Pharm Pharmacol; 1996 Jan; 48(1):71-6. PubMed ID: 8722500
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of antidotes and their combinations in the treatment of acute carbamate poisoning in rats.
Stojiljković MP; Škrbić R; Jokanović M; Kilibarda V; Bokonjić D; Vulović M
Toxicology; 2018 Sep; 408():113-124. PubMed ID: 30176331
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms involved in the development of tolerance to DFP toxicity.
Gupta RC; Patterson GT; Dettbarn WD
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S17-28. PubMed ID: 4092885
[TBL] [Abstract][Full Text] [Related]
25. Effects of hexamethonium, phenothiazines, propranolol and ephedrine on acetylcholinesterase carbamylation by physostigmine, aldicarb and carbaryl: interaction between the active site and the functionally distinct peripheral sites in acetylcholinesterase.
Singh AK; Spassova D
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Jan; 119(1):97-105. PubMed ID: 9568379
[TBL] [Abstract][Full Text] [Related]
26. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
[TBL] [Abstract][Full Text] [Related]
27. In Vivo Effects of Neostigmine and Physostigmine on Neutrophil Functions and Evaluation of Acetylcholinesterase and Butyrylcholinesterase as Inflammatory Markers during Experimental Sepsis in Rats.
Bitzinger DI; Gruber M; Tümmler S; Malsy M; Seyfried T; Weber F; Redel A; Graf BM; Zausig YA
Mediators Inflamm; 2019; 2019():8274903. PubMed ID: 30804708
[TBL] [Abstract][Full Text] [Related]
28. Successive organophosphate inhibition and oxime reactivation reveals distinct responses of recombinant human cholinesterase variants.
Schwarz M; Loewenstein-Lichtenstein Y; Glick D; Liao J; Norgaard-Pedersen B; Soreq H
Brain Res Mol Brain Res; 1995 Jul; 31(1-2):101-10. PubMed ID: 7476018
[TBL] [Abstract][Full Text] [Related]
29. Electrophysiological estimation of the actions of acetylcholinesterase inhibitors on acetylcholine receptor and cholinesterase in physically isolated Aplysia neurones.
Oyama Y; Hori N; Evans ML; Allen CN; Carpenter DO
Br J Pharmacol; 1989 Mar; 96(3):573-82. PubMed ID: 2720293
[TBL] [Abstract][Full Text] [Related]
30. Planarian cholinesterase: in vitro characterization of an evolutionarily ancient enzyme to study organophosphorus pesticide toxicity and reactivation.
Hagstrom D; Hirokawa H; Zhang L; Radic Z; Taylor P; Collins ES
Arch Toxicol; 2017 Aug; 91(8):2837-2847. PubMed ID: 27990564
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE/BuChE and 15-LOX.
Pourabdi L; Khoobi M; Nadri H; Moradi A; Moghadam FH; Emami S; Mojtahedi MM; Haririan I; Forootanfar H; Ameri A; Foroumadi A; Shafiee A
Eur J Med Chem; 2016 Nov; 123():298-308. PubMed ID: 27484515
[TBL] [Abstract][Full Text] [Related]
32. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.
Loewenstein Y; Gnatt A; Neville LF; Soreq H
J Mol Biol; 1993 Nov; 234(2):289-96. PubMed ID: 8230213
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.
Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS
Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
[TBL] [Abstract][Full Text] [Related]
35. The mechanism for the inhibition of acetylcholinesterases by irinotecan (CPT-11).
Dodds HM; Rivory LP
Mol Pharmacol; 1999 Dec; 56(6):1346-53. PubMed ID: 10570064
[TBL] [Abstract][Full Text] [Related]
36. Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats.
Xiao WB; Nordberg A; Zhang X
J Pharmacol Exp Ther; 1993 May; 265(2):759-64. PubMed ID: 8496822
[TBL] [Abstract][Full Text] [Related]
37. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoids differentially control synthesis of acetylcholinesterase and butyrylcholinesterase in rat liver and brain.
Weber U; Brank M; Grubic Z
Chem Biol Interact; 1999 May; 119-120():341-7. PubMed ID: 10421470
[TBL] [Abstract][Full Text] [Related]
39. The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase.
Petzer A; Harvey BH; Petzer JP
Toxicol Appl Pharmacol; 2014 Feb; 274(3):488-93. PubMed ID: 24161345
[TBL] [Abstract][Full Text] [Related]
40. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
